Integrating Gemcitabine-Based Therapy With AdipoRon Enhances Growth Inhibition in Human PDAC Cell Lines

MLA

Angela Ragone, et al. “Integrating Gemcitabine-Based Therapy With AdipoRon Enhances Growth Inhibition in Human PDAC Cell Lines.” Frontiers in Pharmacology, vol. 13, Feb. 2022. EBSCOhost, https://doi.org/10.3389/fphar.2022.837503.

APA

Angela Ragone, Alessia Salzillo, Annamaria Spina, Silvio Naviglio, & Luigi Sapio. (2022). Integrating Gemcitabine-Based Therapy With AdipoRon Enhances Growth Inhibition in Human PDAC Cell Lines. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.837503

Chicago

Angela Ragone, Alessia Salzillo, Annamaria Spina, Silvio Naviglio, and Luigi Sapio. 2022. “Integrating Gemcitabine-Based Therapy With AdipoRon Enhances Growth Inhibition in Human PDAC Cell Lines.” Frontiers in Pharmacology 13 (February). doi:10.3389/fphar.2022.837503.